TMEM184B
Transmembrane protein 184B
Also known as: C22orf5, DKFZP586A1024, FM08, HS5O6A, T184B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y519
- Gene
- TMEM184B
- Ensembl
- ENSG00000198792
- Chromosome
- 22
- Canonical length
- 407 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
407 residues, UniProt reviewed canonical sequence.
>Q9Y519|TMEM184B
1 MTVRGDVLAP DPASPTTAAA SPSVSVIPEG SPTAMEQPVF LMTTAAQAIS GFFVWTALLI
61 TCHQIYMHLR CYSCPNEQRY IVRILFIVPI YAFDSWLSLL FFTNDQYYVY FGTVRDCYEA
121 LVIYNFLSLC YEYLGGESSI MSEIRGKPIE SSCMYGTCCL WGKTYSIGFL RFCKQATLQF
181 CVVKPLMAVS TVVLQAFGKY RDGDFDVTSG YLYVTIIYNI SVSLALYALF LFYFATRELL
241 SPYSPVLKFF MVKSVIFLSF WQGMLLAILE KCGAIPKIHS ARVSVGEGTV AAGYQDFIIC
301 VEMFFAALAL RHAFTYKVYA DKRLDAQGRC APMKSISSSL KETMNPHDIV QDAIHNFSPA
361 YQQYTQQSTL EPGPTWRGGA HGLSRSHSLS GARDNEKTLL LSSDDEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM184B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 68 nTPM
- cerebral cortex: 66 nTPM
- cerebellum: 45 nTPM
- hippocampal formation: 42 nTPM
- midbrain: 40 nTPM
- amygdala: 39 nTPM
Single-cell type
- müller glia: 170 nCPM
- somatotrophs: 169 nCPM
- thyrotrophs: 167 nCPM
- syncytiotrophoblasts: 154 nCPM
- bergmann glia: 140 nCPM
- endometrial luminal cells: 137 nCPM
Immune cell
- basophil: 14 nTPM
- neutrophil: 11 nTPM
- plasmacytoid DC: 7 nTPM
- NK-cell: 6.2 nTPM
- gdT-cell: 5.3 nTPM
- eosinophil: 4.7 nTPM
Brain region
- white matter: 137 nTPM
- medulla oblongata: 119 nTPM
- thalamus: 117 nTPM
- midbrain: 116 nTPM
- pons: 116 nTPM
- cerebellum: 114 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.37
- gnomAD missense Z
- 2.06
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM184B as an antibody target. Whether an autoantibody or antibody against TMEM184B could matter depends on whether native TMEM184B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM184B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM184B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...